Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Raw Materials (2016 - 2025)

Historic Raw Materials for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $178.5 million.

  • Phibro Animal Health's Raw Materials rose 2233.69% to $178.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $178.5 million, marking a year-over-year increase of 2233.69%. This contributed to the annual value of $162.6 million for FY2025, which is 12339.04% up from last year.
  • Latest data reveals that Phibro Animal Health reported Raw Materials of $178.5 million as of Q4 2025, which was up 2233.69% from $166.4 million recorded in Q3 2025.
  • Phibro Animal Health's 5-year Raw Materials high stood at $178.5 million for Q4 2025, and its period low was $59.8 million during Q2 2021.
  • In the last 5 years, Phibro Animal Health's Raw Materials had a median value of $84.8 million in 2022 and averaged $99.5 million.
  • As far as peak fluctuations go, Phibro Animal Health's Raw Materials tumbled by 2020.67% in 2023, and later soared by 12339.04% in 2025.
  • Phibro Animal Health's Raw Materials (Quarter) stood at $71.3 million in 2021, then soared by 35.44% to $96.6 million in 2022, then dropped by 20.21% to $77.0 million in 2023, then soared by 89.35% to $145.9 million in 2024, then increased by 22.34% to $178.5 million in 2025.
  • Its Raw Materials stands at $178.5 million for Q4 2025, versus $166.4 million for Q3 2025 and $162.6 million for Q2 2025.